Published in Am J Transplant on April 11, 2017
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab (2006) 3.49
Malignancy-related mortality following kidney transplantation is common. Kidney Int (2013) 2.70
Thyroid cancer mortality and incidence: a global overview. Int J Cancer (2014) 2.63
Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab (2007) 2.26
Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control (2008) 2.17
Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada. JAMA Oncol (2016) 2.14
Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol (2009) 1.74
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation (2004) 1.68
Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int (2005) 1.63
A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control (1999) 1.50
Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev (1996) 1.36
Cancer in end-stage renal disease: potential factors involved -editorial-. Am J Nephrol (1998) 1.28
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study. Am J Transplant (2012) 1.03
Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans. J Clin Endocrinol Metab (2012) 0.99
Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int J Epidemiol (2014) 0.98
The changing incidence of thyroid cancer. Nat Rev Endocrinol (2016) 0.96
Management of solid tumours in organ-transplant recipients. Lancet Oncol (2007) 0.95
Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst (2014) 0.90
Association of antibody induction immunosuppression with cancer after kidney transplantation. Transplantation (2015) 0.90
Cancer mortality in kidney transplantation. Am J Transplant (2009) 0.86
Melanoma Risk and Survival among Organ Transplant Recipients. J Invest Dermatol (2015) 0.85
De novo cancer-related death in Australian liver and cardiothoracic transplant recipients. Am J Transplant (2013) 0.85
Cancer risk in individuals with benign thyroid disorders. Thyroid (1998) 0.82
Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies. Thyroid (2016) 0.82
Thyroid cancer and renal transplantation: a meta-analysis. Endocr Relat Cancer (2010) 0.81
Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals. J Am Soc Nephrol (2015) 0.81
Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. Am J Transplant (2016) 0.79
Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history. Transplantation (2013) 0.76
De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature. J Surg Oncol (2017) 0.76
Sirolimus use and cancer incidence among US kidney transplant recipients. Am J Transplant (2014) 0.84